Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
Status:
RECRUITING
Trial end date:
2026-05-10
Target enrollment:
Participant gender:
Summary
The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for Lung injury caused by major infectious diseases.